1. Home
  2. PLAB vs BBNX Comparison

PLAB vs BBNX Comparison

Compare PLAB & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLAB
  • BBNX
  • Stock Information
  • Founded
  • PLAB 1969
  • BBNX 2015
  • Country
  • PLAB United States
  • BBNX United States
  • Employees
  • PLAB N/A
  • BBNX N/A
  • Industry
  • PLAB Semiconductors
  • BBNX Medical/Dental Instruments
  • Sector
  • PLAB Technology
  • BBNX Health Care
  • Exchange
  • PLAB Nasdaq
  • BBNX Nasdaq
  • Market Cap
  • PLAB 1.2B
  • BBNX 967.6M
  • IPO Year
  • PLAB 1987
  • BBNX 2025
  • Fundamental
  • Price
  • PLAB $23.11
  • BBNX $20.05
  • Analyst Decision
  • PLAB Strong Buy
  • BBNX Strong Buy
  • Analyst Count
  • PLAB 2
  • BBNX 10
  • Target Price
  • PLAB $31.00
  • BBNX $26.10
  • AVG Volume (30 Days)
  • PLAB 870.0K
  • BBNX 602.9K
  • Earning Date
  • PLAB 08-27-2025
  • BBNX 10-28-2025
  • Dividend Yield
  • PLAB N/A
  • BBNX N/A
  • EPS Growth
  • PLAB N/A
  • BBNX N/A
  • EPS
  • PLAB 1.77
  • BBNX N/A
  • Revenue
  • PLAB $856,152,000.00
  • BBNX $78,022,000.00
  • Revenue This Year
  • PLAB N/A
  • BBNX $43.04
  • Revenue Next Year
  • PLAB $3.87
  • BBNX $35.60
  • P/E Ratio
  • PLAB $13.03
  • BBNX N/A
  • Revenue Growth
  • PLAB N/A
  • BBNX 550.45
  • 52 Week Low
  • PLAB $16.46
  • BBNX $8.89
  • 52 Week High
  • PLAB $31.60
  • BBNX $26.66
  • Technical
  • Relative Strength Index (RSI)
  • PLAB 47.78
  • BBNX 42.55
  • Support Level
  • PLAB $22.02
  • BBNX $20.80
  • Resistance Level
  • PLAB $24.15
  • BBNX $23.41
  • Average True Range (ATR)
  • PLAB 0.99
  • BBNX 1.28
  • MACD
  • PLAB -0.16
  • BBNX -0.26
  • Stochastic Oscillator
  • PLAB 29.02
  • BBNX 23.59

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Share on Social Networks: